2014
DOI: 10.1021/jo500520x
|View full text |Cite
|
Sign up to set email alerts
|

Emission Tuning of Fluorescent Kinase Inhibitors: Conjugation Length and Substituent Effects

Abstract: Fluorescent N-phenyl-4-aminoquinazoline probes targeting the ATP-binding pocket of the ERBB family of receptor tyrosine kinases are reported. Extension of the aromatic quinazoline core with fluorophore “arms” through substitution at the 6- position of the quinazoline core with phenyl, styryl, and phenylbutadienyl moieties was predicted by means of TD-DFT calculations to produce probes with tunable photoexcitation energies and excited states possessing charge-transfer character. Optical spectroscopy identified … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
24
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(24 citation statements)
references
References 25 publications
0
24
0
Order By: Relevance
“…The 6-vinyl-substituted 4-anilinoquinazoline derivative B (CP-724,714), on the other hand, is a selective ERBB2 angiogenesis inhibitor under investigation for the treatment of breast, ovarian and other types of cancer ( Figure 1) [13]. The analogous (E)-6-(4-dimethylaminostyryl)-N-phenylquinazolin-4-amine C was found to exhibit ERBB2-induced fluorescence thus demonstrating its utility as a turn-on fluorescence kinase inhibitor in human cervical cancer (MCF-7) cells [14]. 2-Phenyl-4-(phenylamino)quinazoline D, on the other hand, has emerged as a potent photosensitizer with anti-proliferative activity and DNA damage in L1210 cells [15].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The 6-vinyl-substituted 4-anilinoquinazoline derivative B (CP-724,714), on the other hand, is a selective ERBB2 angiogenesis inhibitor under investigation for the treatment of breast, ovarian and other types of cancer ( Figure 1) [13]. The analogous (E)-6-(4-dimethylaminostyryl)-N-phenylquinazolin-4-amine C was found to exhibit ERBB2-induced fluorescence thus demonstrating its utility as a turn-on fluorescence kinase inhibitor in human cervical cancer (MCF-7) cells [14]. 2-Phenyl-4-(phenylamino)quinazoline D, on the other hand, has emerged as a potent photosensitizer with anti-proliferative activity and DNA damage in L1210 cells [15].…”
Section: Introductionmentioning
confidence: 99%
“…This compound was also found to induce programmed cell death in leukemia cells through mitochondrial/caspase 9/caspase 3-dependent pathway upon UVA irradiation [15]. utility as a turn-on fluorescence kinase inhibitor in human cervical cancer (MCF-7) cells [14]. 2-Phenyl-4-(phenylamino)quinazoline D, on the other hand, has emerged as a potent photosensitizer with antiproliferative activity and DNA damage in L1210 cells [15].…”
Section: Introductionmentioning
confidence: 99%
“…In the last decades, compounds with photochromic properties have attracted considerable attention for the creation of devices for the registration and storage of optical information, molecular switches, chemical sensors, and reagents for fluorescence spectroscopy , . It is known that 2‐aryl(hetaryl)‐ and 2‐styrylquinazolinones show distinctive fluorescence properties and therefore have potential for the creation of non‐linear optical generators . Variation of the structures, namely, the substituents in the heterocyclic and aryl fragments, allows one to obtain optical systems with various spectral parameters .…”
Section: Introductionmentioning
confidence: 99%
“…3 Interest in these compounds is not only limited to the synthesis or development of more diverse and complex bioactive derivatives for structure-activity relationship evaluations, but has since been extended to focus on their photophysical properties as potential fluorescence probes. [4][5][6][7][8][9] Fluorescent carbosubstituted quinazolines such as the medicinally important Lapatinib, for example, functions as an environmentally responsive 'turn-on' fluorophore. 8 Its analogue, (E)-6-(4-dimethylaminostyryl)-Nphenylquinazolin-4-amine, acts as a turn-on fluorescence kinase inhibitor in MCF7 cells.…”
Section: Introductionmentioning
confidence: 99%